Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation

Piotr Ozieranski; Emily Rickard; Shai Mulinari

doi:10.1136/bmjebm-2024-113101

Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation

Department of Social and Policy Sciences
Lund University

Research output: Contribution to journal › Article › peer-review

3 Citations (SciVal)

Original language	English
Pages (from-to)	7-12
Number of pages	6
Journal	BMJ Evidence-Based Medicine
Volume	31
Early online date	7 Jan 2025
DOIs	https://doi.org/10.1136/bmjebm-2024-113101
Publication status	Published - 21 Jan 2026

Keywords

Ethics
Policy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmjebm-2024-113101Licence: CC BY

Cite this

@article{b4568a84bc894ae38a07203bbc854675,

title = "Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation",

keywords = "Ethics, Policy",

author = "Piotr Ozieranski and Emily Rickard and Shai Mulinari",

year = "2026",

month = jan,

day = "21",

doi = "10.1136/bmjebm-2024-113101",

language = "English",

volume = "31",

pages = "7--12",

journal = "BMJ Evidence-Based Medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Unknowns of drug company payment disclosure

T2 - why the UK needs payment transparency legislation

AU - Ozieranski, Piotr

AU - Rickard, Emily

AU - Mulinari, Shai

PY - 2026/1/21

Y1 - 2026/1/21

KW - Ethics

KW - Policy

UR - https://www.scopus.com/pages/publications/85214529322

U2 - 10.1136/bmjebm-2024-113101

DO - 10.1136/bmjebm-2024-113101

M3 - Article

C2 - 39773928

SN - 2515-446X

VL - 31

SP - 7

EP - 12

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

ER -

Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations

Cite this

Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Projects

Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations

Cite this